These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37955644)

  • 1. Diabetic Ketoacidosis at Diagnosis in Youth with Type 1 Diabetes Is Associated with a Higher Hemoglobin A1c Even with Intensive Insulin Management.
    Zaharieva DP; Ding VY; Addala A; Prahalad P; Bishop F; Hood KK; Desai M; Wilson DM; Buckingham BA; Maahs DM
    Diabetes Technol Ther; 2024 Mar; 26(3):176-183. PubMed ID: 37955644
    [No Abstract]   [Full Text] [Related]  

  • 2. Disparities in Hemoglobin A1c Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring.
    Addala A; Ding V; Zaharieva DP; Bishop FK; Adams AS; King AC; Johari R; Scheinker D; Hood KK; Desai M; Maahs DM; Prahalad P;
    JAMA Netw Open; 2023 Apr; 6(4):e238881. PubMed ID: 37074715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: The SEARCH for diabetes in youth study.
    Duca LM; Reboussin BA; Pihoker C; Imperatore G; Saydah S; Mayer-Davis E; Rewers A; Dabelea D
    Pediatr Diabetes; 2019 Mar; 20(2):172-179. PubMed ID: 30556249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study.
    Prahalad P; Ding VY; Zaharieva DP; Addala A; Johari R; Scheinker D; Desai M; Hood K; Maahs DM
    J Clin Endocrinol Metab; 2022 Mar; 107(4):998-1008. PubMed ID: 34850024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Glycemic Outcomes During the MiniMed
    Pihoker C; Shulman DI; Forlenza GP; Kaiserman KB; Sherr JL; Thrasher JR; Buckingham BA; Kipnes MS; Bode BW; Carlson AL; Lee SW; Latif K; Liljenquist DR; Slover RH; Dai Z; Niu F; Shin J; Jonkers RAM; Roy A; Grosman B; Vella M; Cordero TL; McVean J; Rhinehart AS; Vigersky RA;
    Diabetes Technol Ther; 2023 Nov; 25(11):755-764. PubMed ID: 37782145
    [No Abstract]   [Full Text] [Related]  

  • 6. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
    Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
    Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Glycemic Outcomes with Closed-Loop Insulin Delivery.
    Lakshman R; Najami M; Allen JM; Ware J; Wilinska ME; Hartnell S; Thankamony A; Randell T; Ghatak A; Besser REJ; Elleri D; Trevelyan N; Campbell FM; Hovorka R; Boughton CK
    Diabetes Technol Ther; 2024 Mar; 26(3):198-202. PubMed ID: 38444312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Ketoacidosis Severity at Diagnosis and Glycaemic Control in the First Year of Childhood Onset Type 1 Diabetes-A Longitudinal Cohort Study.
    Khanolkar AR; Amin R; Taylor-Robinson D; Viner RM; Warner J; Gevers EF; Stephenson T
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.
    Garg SK; Grunberger G; Weinstock R; Lawson ML; Hirsch IB; DiMeglio LA; Pop-Busui R; Philis-Tsimikas A; Kipnes M; Liljenquist DR; Brazg RL; Kudva YC; Buckingham BA; McGill JB; Carlson AL; Criego AB; Christiansen MP; Kaiserman KB; Griffin KJ; Forlenza GP; Bode BW; Slover RH; Keiter A; Ling C; Marinos B; Cordero TL; Shin J; Lee SW; Rhinehart AS; Vigersky RA;
    Diabetes Technol Ther; 2023 Jan; 25(1):1-12. PubMed ID: 36472543
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes Predicts Poor Long-term Glycemic Control.
    Duca LM; Wang B; Rewers M; Rewers A
    Diabetes Care; 2017 Sep; 40(9):1249-1255. PubMed ID: 28667128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of diabetic ketoacidosis, severe hypoglycemia and glycemic control among children and young adults with type 1 diabetes mellitus treated with premixed versus basal-bolus insulin therapy.
    Chou WY; Li YR; Chan WK; Chen ST
    Biomed J; 2018 Dec; 41(6):348-355. PubMed ID: 30709576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of school-supervised ultra-long-acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study.
    Nally LM; Sherr JL; Tichy E; Weyman K; Urban A; Shabanova V; McCollum S; Steffen A; Tamborlane WV; Van Name M
    Diabet Med; 2023 Oct; 40(10):e15123. PubMed ID: 37078999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry.
    Cengiz E; Xing D; Wong JC; Wolfsdorf JI; Haymond MW; Rewers A; Shanmugham S; Tamborlane WV; Willi SM; Seiple DL; Miller KM; DuBose SN; Beck RW;
    Pediatr Diabetes; 2013 Sep; 14(6):447-54. PubMed ID: 23469984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Degludec in Adolescents with Type 1 Diabetes: Is Newer Better? - A Retrospective Self-Control Case Series in Adolescents with a History of Diabetic Ketoacidosis.
    Schmitt J; Scott ML
    Horm Res Paediatr; 2019; 92(3):179-185. PubMed ID: 31865335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Modality-Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study.
    Hoshina S; Andersen GS; Jørgensen ME; Ridderstråle M; Vistisen D; Andersen HU
    Diabetes Technol Ther; 2018 Mar; 20(3):229-234. PubMed ID: 29437465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study.
    Bode BW; Cengiz E; Wadwa RP; Banks P; Danne T; Kushner JA; McGuire DK; Peters AL; Strumph P; Sawhney S
    Diabetes Technol Ther; 2021 Jan; 23(1):59-69. PubMed ID: 32640846
    [No Abstract]   [Full Text] [Related]  

  • 18. Open-source Artificial Pancreas Systems Are Safe and Effective When Supported In-clinic: Outcomes in 248 Consecutive Type 1 Diabetes Clients.
    Samuel P; Khan N; Klein G; Skobkarev S; Mammon B; Fournier M; Hawke K; Weissinger A; Elliott T
    Can J Diabetes; 2024 Feb; 48(1):59-65.e1. PubMed ID: 37802366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the presence of diabetic ketoacidosis: A retrospective analysis of patients with type 1 diabetes in Saudi Arabia.
    Al Hayek AA; Robert AA; Al-Shaikh R; Alhojele M; Aloufi S; Sabri D; Alenazi M; Hassan AH; Al Dawish M
    Diabetes Metab Syndr; 2020; 14(6):2117-2122. PubMed ID: 33395771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate and severe diabetic ketoacidosis at type 1 diabetes onset in children over two decades: A population-based study of prevalence and long-term glycemic outcomes.
    Clapin H; Smith G; Vijayanand S; Jones T; Davis E; Haynes A
    Pediatr Diabetes; 2022 Jun; 23(4):473-479. PubMed ID: 35218122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.